Almost overnight, the global pandemic forever changed the healthcare industry. <n>
Aside from the broader industry ramifications, the shaping influence of Covid-19 also profoundly impacted our healthcare professional liability (HPL) and general liability (GL) marketplace.
Over the course of the last three months, medical malpractice insurers have had to rapidly assess the far-reaching consequences while simultaneously fielding countless complex coverage questions, diving into the spring renewal season and trying to understand the implications of a growing number of Covid-related claims notices. In the midst of that, insurers have also been crafting and evolving their coverage responses to the pandemic.
As result, the market has released a considerable variety of clauses that seek to limit and/or exclude coverage for Covid-related claims (and more) in HPL/GL policy forms.
We hope you find this report informative and welcome any feedback you may have.
Kirsten Beasley Head of Healthcare Broking North America Willis Towers Watson